¤K¤Q¤E¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ®ø¤Æ¬ì

(A) 1. ¤@¦ì 76 ·³¯f¤H¨Ó°|´NÂå¡A¥D¶D 6 ­Ó¤ë¨Ó¦³ÄY­«¸¡µh¡A¥D­nµo¥Í¦b¶i­¹«á 1~2 ¤p®É¡A¦]¦¹¥L¬Û·í®`©È¶i­¹¡C¥LªºÅé­«©úÅã¤U­°¡C¤j«KÃC¦â¦p±`¡A¥BµL¼ç¦å¤ÏÀ³¡C½Ð°Ý¨ä¶EÂ_³Ì¥i¯à¬°¤U¦C¦óªÌ¡H
A.Mesenteric angina
B.Diverticulosis
C.Duodenal ulcer
D.Irritable bowel syndrome
E.Colon cancer
 
(D) 2. ¤@¦ì¯f¤H¦í°|«á¡A³Q¶EÂ_¦³¸¡¤ô¡A©â¨ú«á°eÀË¡Aµ²ªG¦p¤U : Albumin = 1.2 g/dL¡ATriglyceride = 1600 mg/dL¡ALDH = 400 U/L ¡AAmylase = 200 U/L¡AWBC = 100/£gL¡AL:N = 60:40¡C¦P¤@¤Ñ©â¦åÀˬdµ²ªG¬° : Albumin = 3.4 g/dL¡ATriglyceride = 120 mg/dL¡ALDH = 360 U/L¡AAmylase = 210 U/L¡C¨ä¯f¦]³Ì¥i¯à¬°¤U¦C¦óªÌ¡H
A.Àù¯g©Ê¸¡½¤ª¢
B.²Óµß©Ê¸¡½¤ª¢
C.µ²®Ö©Ê¸¡½¤ª¢
D.²O¤ÚºÞªý¶ë
E.¨xªù¯ß°ªÀ£
 
(D) 3. ¯f¤H¦]²`«×¶À¯n¦í°|¡C¨ä©â¦åÀˬdµ²ªG¦p¤U : Bil(T/D) = 35/28 mg/dL¡AGOT = 200 (<41)¡AGPT = 55 (<41)¡AAlbumin = 3.3 g/dL¡AGlobulin = 4.3 g/dL¡AALP = 750 (<238)¡A£^-GT = 540 (<50)¡ALDH = 800 (<450)¡AWBC = 4300/£g L¡A Hb = 8.5 g/dL¡APlatelet count = 130K/£gL¡AProthrombin time = 30" (Control : 11")¡A¸g Vit. K1 ª`®g 4 ¤Ñ«á¡AProthrombin time = 13" (Control : 11")¡C¤U¦C¦UºØ¶EÂ_¡A¦óªÌ³Ì¦³¥i¯à¡H
A.¦³ DIC (Disseminated Intravascular Coagulation) ²{¶H¡AÀ³»°§Ö¨Ï¥Î heparinªvÀø
B.©úÅã¨x°IºÜ¡AÀ³¾¨§Ö°µ¨xŦ²¾´Ó
C.¥½´Á¨xµw¤Æ¨Ö¦³¨xªù¯ß°ªÀ£
D.¦³Áx¥Äº¢¯d²{¶H¡A¥B¦X¨Ö·»¦å±¡ªp
E.¥i¯à¦³«æ©ÊÃĪ«©Ê¨x¯f
 
(A) 4. ¹ï©ó­¹¹DÀR¯ß¦±±i¥X¦åªº±wªÌ¡A¤U¦C¦UºØªvÀø¤è¦¡¡A¦óªÌ¿ù»~¡H
A.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥Î H2-receptor blocker
B.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥Î Vasopressin ©Î¨ä­l¥Íª«
C.«æ©Ê¥X¦å®É¡A¥i¦Ò¼{¬I¥H Endoscopic sclerotherapy ©Î ligation
D.±¡ªpí©w«á¡A¥i¦Ò¼{¨Ï¥Î propranolol µ¥«D¿ï¾Ü©Ê£]- adrenergic blocker ¨Ó¹w¨¾¨ä¦A¥X¦å
E.¤@¦A¥X¦åªÌ¡A¥i¦Ò¼{¨Ï¥Î TIPS (Transjugular Intrahepatic Portosystemic Shunting¡A¤@ºØ¥´³q¨xÀR¯ß©M¨xªù¯ß¤§§Þ³N)
 
(C) 5. ¨xµw¤Æ¨Ö¦³¸¡¤ô¤§±wªÌ¡A¨äÅ餺·|§e²{¤U¦C¦UºØ¯fºA¥Í²z²{¶H¡A°£¤F¡G
A.Total body sodium ¼W¥[
B.Effective intravascular volume ´î¤Ö
C.Plasma renin activity ¤Î aldosterone ´î¤Ö
D.Portal venous pressure ¼W¤j
E.Plasma oncotic pressure ­°§C
 
(D) 6. ¤@¦ì¨k©Ê¯f¤H¦]¬¡°Ê©Ê³Ý®§ (exertional dyspnea) ¤Î¥k¤W¸¡¤£¾A¦Ó¦í°|¡AÂå®v©ó²z¾ÇÀˬd¤¤µo²{¯f¤H½§¦â¸û±`¤H¶Â¡A¤ßŦÂX¤j¡A¨x¡BµÊ©úÅã¸~¤j¡A¥B¦³¤UªÏ¤ô¸~¡C¤U¦C¦U¶µ±Ô­z¦óªÌ¿ù»~¡H
A.¥»¯f¤H¦³¤ßŦ°IºÜ²{¶H
B.Serum ferritin ¬O½T¥ß¶EÂ_¤§³Ì¨Î¤u¨ã¤§¤@
C.Phlebotomy ¬°ªvÀø¤èªk¤§¤@
D.¥i¨Ï¥Î D-penicillamine ªvÀø¤§
E.À³±K¤Á°lÂܨä¦å¿}­È
 
(E) 7. Ãö©ó serum amylase ¤§±Ô­z¡A¤U¦C¦óªÌ¿ù»~¡H
A.¦å²M amylase ­È¤É°ª¡A°£¤F«æ©Ê¯ØŦª¢¥~¡A¤]¥i¯à¦]ª`®g morphine ¦Ó³y¦¨
B.¦å²M amylase ¦³ P type ¤Î S type ¨âºØ isoenzymes
C.¥¿±`¤H¤§ P type isoenzyme ¦û¦å¤¤ amylase ¤§ 35~45%
D.¶EÂ_«æ©Ê¯ØŦª¢¡Aamylase isoenzyme ¸û total amylase ¦³»ù­È
E.¶EÂ_«æ©Ê¯ØŦª¢¡ACam/Ccr ¦Ü¤µ¤´³Q»{¬°¸û serum amylase ¦³¥Î
 
(E) 8. ¤@¦ì«æ©Ê¯ØŦª¢±wªÌ¦í°|«á¡A¯f±¡³vº¥§ïµ½¦Ó¥X°|¡C¦ý¦b¥X°|«á²Ä 20 ¤Ñ¡A¥ª¤W¸¡¤Sµh°_¨Ó¡A¦³®É¥B·|µh¦Ü­I«á¡C©ó¬O¤S³Q°e¦Ü«æ¶E«Ç¡A²z¾ÇÀˬdµo²{¨{ÂÀ¥ª¤W¤èÁô¬ù¥iºN¨ì¤@­Ó¬É­­¤£©ú½T¤§¸~½F¡A¥Î¤OÀ£·|µh¡C¯f¤H¤@ª½¨S¦³µo¿N¡A¨ä¦å²M amylase ­È¦A¤É¦Ü 420 U/L (<200)¡C¨ä³Ì¥i¯à¤§¶EÂ_¬°¤U¦C¦óªÌ¡H
A.Spleen infarction
B.Gastric ulcer
C.Retroperitoneal hemorrhage
D.Pancreatic abscess
E.Pancreatic pseudocyst
 
(B) 9. ¤@¦ì 17 ·³¨k¥Í¦]¸¡µÈ¦Ó¦í°|¡A²z¾ÇÀˬdµo²{¥L¦³ spider naevi, palmar erythema, shifting dullness ¤Î splenomegaly¡C©â¦åÀˬdµ²ªG¦p¤U : Albumin = 3.0 (>3.7) g/dL¡AGOT = 70 (<41)¡AGPT=65 (<41)¡ABil (T/D) = 1.2/0.5 (<1.0/<0.4) mg/dL¡AProthrombin time = 17" (Control : 12")¡AWBC = 2900¡APlatelet = 98K (>130K)¡AHb = 11.0¡Aplasma iron = 75 (50~150)£gg/dL¡ATIBC = 350 (250~370)£gg/dL¡Aserum ferritin = 180 (10~200)£gg/L¡Aserum ceruloplasmin = 15 (>20) mg/dL¡Aurine copper = 150£gg/day¡C¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.³o¬O¤@¦ì¦~»´ªº¨xµw¤Æ±wªÌ
B.¥Lªº¨xµw¤Æ¬O Hemochromatosis ³y¦¨ªº
C.À³ª`·N¨ä®a±Ú¾ú
D.À³¸Ó·Ó·|²´¬ìÂå®v
E.¥L«Ü¥i¯à¦³¨xªù¯ß°ªÀ£
 
(B) 10. ¨x²Ó­MÀù¤@ª½°ª©~¥xÆW¦a°ÏÀù¯g¦º¦]¤§²Ä¤@©Î²Ä¤G¦ì¡C¨x²Ó­MÀù­Y¯à¦­´Á³Qµo²{¡A¨ä¹w«á©|¨Î¡C¤U¦C¦³Ãö¨x²Ó­MÀù¿zÀˤ§±Ô­z¡A¦óªÌ¿ù»~¡H (1) ©Ò¦³ºC©Ê B «¬©Î C «¬¨xª¢±a­ìªÌ³£À³©w´Á±µ¨ü¿zÀË (2) ©Ò¦³¨xµw¤Æ±wªÌ³£À³©w´Á±µ¨ü¿zÀË (3) ¥u¦³¤w¹F¨xµw¤ÆªººC©Ê B «¬¨xª¢±a­ìªÌ¤~»Ý©w´Á±µ¨ü¿zÀË (4) ©w´Á¿zÀˤ§¤u¨ãÀ³¥]¬A¹q¸£Â_¼hÄá¼v (CT) ©M¦å²M¥ÒºØ­L¨à³J¥Õ (£\-fetoprotein) (5) 25·³¤k©Ê©â¦åÀˬdµo²{¥ÒºØ­L¨à³J¥Õ­È°ª¹F 250 ng/mL (<20)¡A¥²©w¬O¿©±w¨x²Ó­MÀù
A.(3)
B.(3)+(4)+(5)
C.(3)+(4)
D.(2)+(3)+(5)
E.(1)+(5)
 
(E) 11. Lamivudine (3-TC) ¬O¥Ø«e¤w¤W¥«ªº¤@ºØ§í¨î B «¬¨xª¢¯f¬r½Æ»sªº¤fªAÃÄ¡C¨ä¨Ï¥ÎÀ³¦Ò¼{¤U¦C¦óªÌ¡H (1) ¥Ñ¨xŦ±Æªn¡A¬GÀ³¨Ì Child's classification ¤§¿n¤À½Õ¾ã¾¯¶q (2) ¥ÑµÇŦ±Æªn¡A¬GÀ³¨Ì Ccr ¤§¼Æ­È½Õ¾ã¾¯¶q (3) «ùÄò¨Ï¥Î¤@¦~¡AB «¬¨xª¢¯f¬r²£¥Í§ÜÃĩʤ§¾÷²v¬ù¬° 15~20% (4) ¥ÎÃÄ«e¦å¤¤ GPT ­È­Y¶W¹L¥¿±`­È¤W­­¤­­¿¡A¨Ï¥Î¤@¦~¤º¤§ªvÀø¦¨¥\²v¥i¹F 60% ¥ª¥k (5) ¤£¾A¥Î©ó¨x©ÎµÇ²¾´Ó«áµo¥ÍºC©Ê B «¬¨xª¢«æ©Êµo§@¤§¯f¤H
A.(1)+(2)+(3)+(4)+(5)
B.(1)+(2)+(3)+(4)
C.(1)+(3)+(4)+(5)
D.(2)+(3)+(4)+(5)
E.(2)+(3)+(4)
 
(B) 12. ¦³Ãö­ìµo©Ê¶¡¥Ö½F (primary mesothelioma) ¤§¤U¦C±Ô­z¡A¦óªÌ¬°»~¡H
A.¦h¼Æ¬°´c©Ê
B.µo¥Í©ó¦Ø½¤ªÌ¸û¸¡½¤ªÌ¤Ö
C.»P¥Û´Ö (asbestos) ±µÄ²¦³Ãö
D.¸¡¤ô¬°º¯¥X²G (exudate)¡A¥i¯à¦å¼Ë
E.¸¡¤ô¤¤¬Á§¿»Ä (hyaluronic acid) §t¶q°ª
 
(C) 13. «æ©Ê¶¡·²©Êµµ½è¯g (acute intermittent porphyria) ±wªÌ¤£·|³y¦¨
A.¸¡µh
B.·NÃѤ£²M
C.°ª¦å¶u
D.¤WªÏµL¤O
E.X ¥úÅã¥Ü¾÷±ñ©Ê¸zªý¶ë
 
(A) 14. ¦³Ãö Zenker's diverticulum ¤§±Ô­z¡A¦óªÌ¬°«D¡H
A.¨ä¶}¤f¦b¤W­¹¹D¬A¬ù¦Ù¤§¤U
B.¾Í«ÇÅܤj®É¥i±N­¹¹D¦V«eÀ½À£
C.À£­¢ÀV³¡¥i²M°£¾Í«Ç¤º®eª«
D.©ñ¸m­GºÞ®É¥i¯à¦ÛµM´¡¶i¾Í«Ç¤º
E.¨äªvÀø¬°¾Í«Ç¤Á°£¡A¦P®É¤Á¶}Àôª¬³n°©«|³ï¦Ù¦×
 
(D) 15. ­¹¹D¹B°Ê§ÎºA (motility pattern) Åã¥Ü¥­·Æ¦Ù³¡¥÷¥¿±`¡A¾î¯¾¦Ù³¡¥÷«h¦¬ÁY®¶´T´î¤Ö (reduced amplitude)¡A¤W­¹¹D¬A¬ù¦Ù§e§CÀ£ª¬ºA¡A¦Ó¥¼ÀH§]Ã`µÎ±i¡A¨ä¥i¯à¤§¶EÂ_¬°¡G
A.­¹¹DµjÅË
B.­¹¹D¥¢¦¢½w (Achalasia)
C.µw¥Ö¯g (Scleroderma)
D.¦hµo©Ê¦Ùª¢ (Polymyositis)
E.¾ý¯»¼ËÅÜ©Ê (Amyloidosis)
 
(C) 16. ­GÖß½¤¤º§t¦³¦hºØ«e¦C¸¢¯À (prostaglandins)¡A¤×¨ä E Ãþ¡A¨ã¦³¤U¦C¦UºØ¾÷Âà¥H«OÅ@­GÖß½¤·l¶Ë¡A°£¤F¡G
A.¨ë¿E­GÖß²G¤Àªc
B.¨ë¿E­G¤Î¤Q¤G«ü¸zÖß½¤¤Àªc­«ºÒ»ÄÆQ (bicarbonate)
C.¨ë¿E¤Àªc­G³J¥ÕúC (pepsin)
D.ºû«ù­GÖßÁU¦å¬y
E.«P¶i¨ü·l­GÖß½¤¤W¥Ö²Ó­M¤§¦A¥Í
 
(E) 17. ¤U¦C¦U¶µ¸ÕÅ秡¥Î©ó°»´ú«ÕªùÁ³±Û±ìµß·P¬V¡A¦ý¸gªvÀø«á¡A¨ä¤¤¦ó¶µ¸ÕÅç¹ï°lÂÜÀˬd¸ûµL·N¸q¡H
A.§¿¯ÀúC¸ÕÅç
B.¯f²z²Õ´¬V¦âÀˬd
C.²Óµß°ö¾i
D.ºÒ 13 ©I§l¸ÕÅç
E.¦å²M«ÕªùÁ³±Û±ìµß§ÜÅé¸ÕÅç
 
(B) 18. ÅKªº§l¦¬³Ì¥D­n³¡¦ì¬O¡G
A.­G
B.¤Q¤G«ü¸z
C.ªÅ¸z
D.°j¸z
E.ª¼¸z
 
(D) 19. «æ©Ê²rÃz©Ê¯Ê¦å©Êµ²¸zª¢ (acute fulminating ischemic colitis) ¤§±Ô­z¡A¤U¦C¦óªÌ¦³»~¡H
A.¯gª¬¬°¿E¯P¤U¸¡¯kµh¡Aª½¸z¥X¦å¡A¤Î§C¦åÀ£
B.²z¾ÇÀˬd¦³¸¡½¤ª¢¯f¼x¡AX ¥úÀˬd¥i¦³©æ«ü¦L¶H (thumb printing)
C.¤j¸zÃèÀˬd¥iµo²{¼ìºÅ¡A¯Ü®z¤Î¿±µÈªº½KÃÎ
D.¦åºÞÄá¼v¦³§U¶EÂ_¤ÎªvÀø
E.¦³®É¥²­n¥H¥~¬ì¤â³N¤Á°£Ãa¦º³¡¥÷
 
(C) 20. ¤U¦C¯ØŦ¤º¤Àªc½F¡A¦óªÌ·|²£¥ÍÃþ¦üÀã¯l¤§¥Ö½§¯f¨_¦bÁy³¡¡B¸¡³¡¤Î¥|ªÏ»·ºÝ¡H
A.Gastrinoma
B.Insulinoma
C.Glucagonoma
D.Somatostatinoma
E.VIPoma
 
(B) 21. ¦³Ãö¨x§½³¡µ²¸`ª¬¼W¥Í (focal nodular hyperplasia)¡A¤U¦C±Ô­z¦óªÌ¦³»~¡H (1) »P¨x²Ó­M¸¢½F¬Û¦ü¡A»P¤fªAÁ×¥¥ÃĦ³Ãö (2) ¤SºÙ¨x¯Ê³´½F (hepatic hamartoma) (3) ³q±`¬°³æ¤@©Ê¡A¦nµo©ó¥ª¸­ (4) ©öµo¥Í¯}µõ¥X¦å (5) ¤Á­±¦×²´Æ[¡A§e²{¤p¸­ª¬
A.1¡B2¡B3
B.1¡B3¡B4
C.1¡B3¡B5
D.2¡B3¡B5
E.3¡B4¡B5
 
(D) 22. ¤U¦C¦³Ãö¨ÅÁÞúC¯Ê¥F¯g (lactase deficiency) ¤§±Ô­z¡A¦óªÌ¥¿½T¡H (1) ±wªÌÁT«K¤§ pH ­È±`¸û§C (2) ¯gª¬±`¶}©l©ó¥®¦~´Á (3) ¥Õ¤H¤§¿©±w²v¤Ö©ó¶Â¤H¤ÎªF¤è¤H (4) ¨ÅÁÞ©I§l²B§t¶q´ú©w¦³§U¶EÂ_ (5) ¹ïÀu¹T¨Å (yogurt) ¥ç¤£¯à§Ô¨ü
A.1¡B2¡B3¡B4
B.2¡B3¡B4¡B5
C.1¡B3¡B4¡B5
D.1¡B3¡B4
E.2¡B3¡B4
 


< ¤K¤Q¤E¦~«×¸ÕÃD¥Ø¿ý >